Test Price
800 AED✅ Home Collection Available
Antiphospholipid Antibody (APLA) Panel Test in UAE | 800 AED | DHA Licensed Lab
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Antiphospholipid Antibody (APLA) Panel detects autoantibodies against phospholipid-binding proteins, providing essential diagnostic evidence for antiphospholipid syndrome (APS) and associated thrombotic events. This combined serologic and coagulation assessment identifies lupus anticoagulant, anticardiolipin antibodies, and anti-β2-glycoprotein I antibodies through dual-method analysis. Specimen processing requires 2 mL serum from one SST tube and 3 mL whole blood in one Blue Top (Sodium Citrate) tube, mixed thoroughly by inversion. Transport to the laboratory within 4 hours is mandatory; if delayed, platelet-poor plasma must be prepared within 1 hour by double centrifugation at 3600 rpm for 15 minutes each, then frozen immediately. Overnight fasting is preferred. A completed Coagulation Requisition Form is required.
| Feature | Our Test (UAE Premium) | Closest Alternative Lab |
|---|---|---|
| Methodology | Electromechanical Clot Detection + ELISA/EIA | Clot Detection Only (Limited Sensitivity) |
| Diagnostic Precision | 99.9% Sensitivity (ISO 15189 Accredited) | Standard Sensitivity, No ISO Guarantee |
| Turnaround Time | Next-Day Report (Mon/Thu by 9 AM sample) | 3–5 Working Days |
| Home Collection | VIP Mobile Phlebotomy & Cold-Chain Courier (8 AM–11 PM) | Limited or Unavailable |
| Insurance & Support | Direct Billing Verification, WhatsApp Clinical Guidance | Standard Reimbursement Only |
Physician Insight & Safety Protocols
Autoimmune serology testing provides critical information for diagnosing antiphospholipid syndrome, but results must be interpreted within the full clinical context. A positive result requires confirmation after 12 weeks and correlation with thrombotic history or pregnancy outcomes. Never discontinue or adjust anticoagulant therapy without explicit guidance from your treating specialist. The laboratory data serves as one component of a comprehensive diagnostic evaluation. — Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
Advisory Considerations Before Testing
Accurate APLA panel results depend on proper pre-analytical handling. Blood samples must be collected in the correct tube types and transported under temperature-controlled conditions within the 4-hour window. If platelet-poor plasma preparation is required, the double-centrifugation protocol must be followed exactly to avoid platelet contamination that can produce false-positive lupus anticoagulant results. Patients should confirm with their physician whether temporary discontinuation of anticoagulants is medically appropriate before sampling.
Exclusion Criteria & Emergency Indicators
This test is not suitable for individuals with active heavy bleeding, severe thrombocytopenia, or those who cannot safely pause anticoagulants per physician guidance. Patients on heparin must stop 1 day prior (with doctor consent); oral anticoagulants require a 7-day washout. Emergency red flags requiring immediate medical attention include sudden chest pain, shortness of breath, unilateral leg swelling, or any signs of stroke during the preparation phase.
Patient FAQ & Clinical Guidance
1. What is the APLA panel used for?
The Antiphospholipid Antibody Panel identifies autoantibodies that increase the risk of blood clots and pregnancy complications. It is the primary laboratory tool for diagnosing antiphospholipid syndrome, helping clinicians determine the underlying cause of recurrent miscarriages, deep vein thrombosis, stroke in young adults, and unexplained thrombocytopenia. Positive results typically indicate the need for long-term anticoagulation therapy under specialist supervision.
2. How should I prepare for the test?
Overnight fasting is preferred for optimal serum quality. You must discuss any blood-thinning medications with your physician ahead of sampling. Heparin should be paused for 1 day and warfarin or acenocoumarol for 7 days, but only after your doctor confirms it is medically safe to do so. Follow the specimen collection and transport instructions carefully to maintain sample integrity and avoid false-positive results from improper handling.
3. What do abnormal results mean?
A positive APLA panel indicates the presence of antiphospholipid antibodies that significantly raise the risk of thrombotic events. However, a single positive result is not sufficient for diagnosis. Repeat testing after 12 weeks is required to confirm persistent positivity. Definitive diagnosis of antiphospholipid syndrome requires clinical correlation with documented thrombosis or pregnancy morbidity alongside laboratory evidence.
UAE Regulatory & Data Privacy Adherence
Your data privacy and clinical safety are protected under UAE Federal Law. All personal health information is handled in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Our DHA-licensed facility maintains ISO 15189 accreditation for medical laboratory quality and competence.
Clinical & Logistical Metadata
| Test Name | Antiphospholipid Antibody (APLA) Panel |
| Price (AED) | 800 AED |
| Turnaround Time | Next-Day Report (Mon/Thu by 9 AM sample) |
| Sample Type / Matrix | Serum & Whole Blood (SST & Sodium Citrate Tubes) |
| Methodology Used | Electromechanical Clot Detection + ELISA/EIA |
| ICD-10-CM Code | D68.61, D68.69 |
| LOINC Code | 95005-6 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians